Osteogenesis imperfecta, type III Clinical Trials

• Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children
  ClinicalTrials.gov Identifier: NCT00106028 - Active, not recruiting
  Osteogenesis Imperfecta
  
• Pamidronate to Treat Osteogenesis Imperfecta in Children
  ClinicalTrials.gov Identifier: NCT00005901 - Recruiting
  Osteogenesis Imperfecta
  
• Growth Hormone Therapy in Osteogenesis Imperfecta
  ClinicalTrials.gov Identifier: NCT00001305 - Recruiting
  Dwarfism; Osteogenesis Imperfecta
  
• Study of Teriparatide (FORTEO) to Treat Adults with Osteogenesis Imperfecta.
  ClinicalTrials.gov Identifier: NCT00131469 - Recruiting
  Osteogenesis Imperfecta
  
• Evaluation and Intervention for the Effects of Osteogenesis Imperfecta
  ClinicalTrials.gov Identifier: NCT00001594 - Recruiting
  Dwarfism; Osteogenesis Imperfecta
  
• Bisphosphonate Treatment of Osteogenesis Imperfecta
  ClinicalTrials.gov Identifier: NCT00063479 - Completed
  Osteogenesis Imperfecta
  
• Osteogenesis Imperfecta
  ClinicalTrials.gov Identifier: NCT00159419 - Recruiting
  Osteogenesis Imperfecta; Osteoporosis; Juvenile Pagets
  
• Efficacy and Safety of Zoledronic Acid in Children (1 -17 Years) with Severe Osteogenesis Imperfecta
  ClinicalTrials.gov Identifier: NCT00131118 - Completed
  Osteogenesis Imperfecta
  
• Marrow Mesenchymal Cell Therapy for Osteogenesis Imperfecta: A Pilot Study
  ClinicalTrials.gov Identifier: NCT00187018 - Completed
  Osteogenesis Imperfecta
  
• Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00151762 - Active, not recruiting
  Type 2 Diabetes
  
• Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)
  ClinicalTrials.gov Identifier: NCT00032487 - Active, not recruiting
  Type 2 diabetes mellitus
  
• Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients with Type 2 Diabetes.
  ClinicalTrials.gov Identifier: NCT00145925 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Efficacy and Safety of Vildagliptin in Patients with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00102388 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Efficacy and Safety of Vildagliptin in Patients with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00106340 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Long-term Study of Starlix+Diovan to Delay Type II Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00097786 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• A Pilot Theraputic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients
  ClinicalTrials.gov Identifier: NCT00568802 - Active, not recruiting
  Muscular Atrophy, Spinal
  
• The Heat Study: 2 Year Lifestyle Intervention in Overweight Women to Encourage Weight Management
  ClinicalTrials.gov Identifier: NCT00128336 - Active, not recruiting
  Obesity; Type 2 Diabetes
  
• EUROPEAN TRIAL OF IMMUNOSUPPRESSION IN SPK Tx.
  ClinicalTrials.gov Identifier: NCT00140543 - Active, not recruiting
  Diabetes Mellitus, Type 1; Diabetic Nephropathy
  
• Effects of Exenatide and Insulin Glargine in Subjects with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00097500 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
  ClinicalTrials.gov Identifier: NCT00528879 - Recruiting
  Type 2 Diabetes
  
• Phase III Trial of Neoadjuvant TS-1 and CDDP for Type 4 and Large Type 3 Gastric Cancer.JCOG0501
  ClinicalTrials.gov Identifier: NCT00252161 - Recruiting
  Gastric Neoplasm
  
• A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise
  ClinicalTrials.gov Identifier: NCT00528372 - Recruiting
  Type 2 Diabetes
  
• Post-Marketing Safety Study of GSK Biological''s Pediarix™ Vaccine.
  ClinicalTrials.gov Identifier: NCT00146835 - Active, not recruiting
  Prophylaxis: Diphtheria, tetanus, pertussis, hepatitis B, poliovirus type 1, type 2 and type 3
  
• Efficacy and Safety In Poorly Controlled Type 2 Diabetics
  ClinicalTrials.gov Identifier: NCT00044460 - Active, not recruiting
  type 2 diabetes
  
• Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY)
  ClinicalTrials.gov Identifier: NCT00081328 - Recruiting
  Diabetes Mellitus, Type II
  
• Efficacy and Safety of Vildagliptin in Patients with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00102466 - Recruiting
  Diabetes Mellitus, Type 2
  
• An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00229658 - Active, not recruiting
  Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
  
• An Investigational Drug in Patients with Type 2 Diabetes Mellitus and Chronic Renal Insufficiency
  ClinicalTrials.gov Identifier: NCT00095056 - Active, not recruiting
  Diabetes Mellitus, Type 2; Chronic Renal Insufficiency
  
• Rosiglitazone Plaque Study
  ClinicalTrials.gov Identifier: NCT00123227 - Active, not recruiting
  Diabetes Mellitus, Type 2; Vascular Diseases; Hypertension
  
• Prospective Study of Patients with Hirsutism
  ClinicalTrials.gov Identifier: NCT00145288 - Active, not recruiting
  Hirsutism; Type 2 Diabetes; Polycystic Ovary Syndrome
  
• A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients with Frequent Headaches
  ClinicalTrials.gov Identifier: NCT00168428 - Active, not recruiting
  Migraine with frequent headache
  
• A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients with Frequent Headaches
  ClinicalTrials.gov Identifier: NCT00156910 - Active, not recruiting
  Migraine with frequent headache
  
• Immunogenicity and Safety of PENTAXIM™ in Indian Population
  ClinicalTrials.gov Identifier: NCT00259337 - Active, not recruiting
  Diphtheria; Tetanus; Polio; Pertussis; Haemophilus Influenzae Type B
  
• Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression
  ClinicalTrials.gov Identifier: NCT00133809 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• An Evaluation of Exenatide and Rosiglitazone in Subjects with Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00135330 - Recruiting
  Diabetes Mellitus, Type 2
  
• Safety and Efficacy Study in Type 1 Diabetes.
  ClinicalTrials.gov Identifier: NCT00127634 - Active, not recruiting
  Diabetes
  
• Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00308737 - Active, not recruiting
  Diabetes Mellitus, Type I; Diabetes Mellitus, Type II
  
• A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00521378 - Active, not recruiting
  Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
  
• Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer
  ClinicalTrials.gov Identifier: NCT00004163 - Active, not recruiting
  salivary gland malignant mixed cell type tumor; salivary gland poorly differentiated carcinoma; stage III salivary gland cancer; ...
  
• A Pilot Therapeutic Trial Using Hydroxyurea in Type II and III Spinal Muscular Atrophy Patients
  ClinicalTrials.gov Identifier: NCT00084006 - Active, not recruiting
  Spinal Muscular Atrophy
  
• Effects of Vitamin B1 in Type 1 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00117026 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Treatment of Elderly Subjects with Psychosis and Behavioral Disturbances Associated with Dementia of the Alzheimer''s Type
  ClinicalTrials.gov Identifier: NCT00160147 - Recruiting
  psychosis and behavioral disturbances associated with dementia of the alzheimer''s type
  
• Study In People With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00196989 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Effect of Metformin in Patients with Type-1 Diabetes with Inadequate Glycaemic Control by Insulin and Diet
  ClinicalTrials.gov Identifier: NCT00118937 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III
  ClinicalTrials.gov Identifier: NCT00439569 - Not yet recruiting
  Spinal Muscular Atrophy Type II; Spinal Muscular Atrophy Type III
  
• Dietary Interventions in Type 2 Obese Diabetic Patients in the Community
  ClinicalTrials.gov Identifier: NCT00520182 - Active, not recruiting
  Diabetes Type 2
  
• Influence of Physical Training on Mitochondrial Function in Type 2 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00365495 - Active, not recruiting
  Type 2 Diabetes
  
• Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache
  ClinicalTrials.gov Identifier: NCT00135122 - Recruiting
  headache, migraine, analgesics, tension type headache
  
• A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1
  ClinicalTrials.gov Identifier: NCT00239148 - Active, not recruiting
  Type 1 Diabetes
  
• A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1
  ClinicalTrials.gov Identifier: NCT00239187 - Active, not recruiting
  Type 2 Diabetes
  
• Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
  ClinicalTrials.gov Identifier: NCT00334503 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• 4 Weeks Treatment of Type II Diabetic Patients With BI 44847
  ClinicalTrials.gov Identifier: NCT00558909 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Surgical Treatment of Non-Obese Type 2 Diabetic Patients With Duodenal Exclusion
  ClinicalTrials.gov Identifier: NCT00566358 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
  ClinicalTrials.gov Identifier: NCT00334399 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients
  ClinicalTrials.gov Identifier: NCT00260234 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
  ClinicalTrials.gov Identifier: NCT00566813 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Family Management of Type 1 Diabetes in Children
  ClinicalTrials.gov Identifier: NCT00273286 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• A 2 Year Random Control Trial of Patients with Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control
  ClinicalTrials.gov Identifier: NCT00133718 - Active, not recruiting
  Diabetes Mellitus; Type 2 Diabetes Mellitus
  
• A Study of the Safety and Efficacy of CNTO 1275 in Subjects With Severe Plaque-Type Psoriasis
  ClinicalTrials.gov Identifier: NCT00267969 - Active, not recruiting
  Psoriasis
  
• Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes
  ClinicalTrials.gov Identifier: NCT00118963 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
  ClinicalTrials.gov Identifier: NCT00100178 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Prevention of GBS Colonization Via Immun
  ClinicalTrials.gov Identifier: NCT00128219 - Active, not recruiting
  Streptococcus group B
  
• RAMYD STUDY
  ClinicalTrials.gov Identifier: NCT00127582 - Recruiting
  Myotonic dystrophy type 1,; Sudden Cardiac Death
  
• Insulin NovoRapid Vs. Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose
  ClinicalTrials.gov Identifier: NCT00145353 - Active, not recruiting
  Type 1 diabetes mellitus
  
• A Randomized, Controlled Study on Ca Blocker Vs. AII Antagonists in Hypertension with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00144144 - Active, not recruiting
  Hypertension; Diabetes Mellitus, Type 2
  
• Avandia™ + Amaryl™ or Avandamet™ Compared with Metformin (AVALANCHE™ Study)
  ClinicalTrials.gov Identifier: NCT00131664 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00279201 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00447382 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Effect of Long Term α-Lipoic Acid Treatment on Endothelial Function in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00490867 - Active, not recruiting
  Type 2 Diabetes
  
• Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy and Pharmacokinetics of Myozyme in Patients with Late-Onset Pompe Disease.
  ClinicalTrials.gov Identifier: NCT00158600 - Active, not recruiting
  Pompe Disease (Late-onset); Glycogen storage disease type II (GSD-II); Acid Maltase Deficiency Disease; Glycogenosis 2
  
• Outcomes and Cost Consequences of Using an Internet Co-Management Module to Improve the Quality of Type 1 Diabetes Care
  ClinicalTrials.gov Identifier: NCT00194558 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Study of Weight Loss Using Gastric Stimulation in Obese Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00200018 - Active, not recruiting
  Severe to Morbid Obesity and Type 2 Diabetes
  
• Placebo-Controlled Study of the Combination of SYR-322 and Pioglitazone HCl in the Treatment of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00328627 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00351884 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00395746 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Natural History Study of Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1
  ClinicalTrials.gov Identifier: NCT00445991 - Active, not recruiting
  Neurofibromatosis Type 1 (nf1); Precancerous/Nonmalignant Condition
  
• Safety and Efficacy of Inhaled Pre-Prandial Human Insulin in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00343980 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Randomized Study of Real-Time Continuous Glucose Monitors in the Management of Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00406133 - Active, not recruiting
  Type 1 Diabetes
  
• Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00202033 - Active, not recruiting
  Type 2 Diabetes
  
• A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
  ClinicalTrials.gov Identifier: NCT00374907 - Active, not recruiting
  Type 2 Diabetes
  
• Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00376038 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00389415 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
  ClinicalTrials.gov Identifier: NCT00460941 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Effect of Real Time Continuous Glucose Monitoring System on the Management of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00536549 - Active, not recruiting
  Type 2 Diabetes
  
• Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH
  ClinicalTrials.gov Identifier: NCT00564018 - Enrolling by invitation
  Type 1 Diabetes
  
• Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin
  ClinicalTrials.gov Identifier: NCT00396071 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00518882 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00330473 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk
  ClinicalTrials.gov Identifier: NCT00179777 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00237237 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Study of SYR-322 Combined With Metformin in the Treatment of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00286442 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Study of SYR-322 Combined With a Sulfonylurea in the Treatment of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00286468 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Study of SYR-322 Combined With Pioglitazone in the Treatment of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00286494 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00325364 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Long-Term Safety Study of Vildagliptin in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00325429 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00393718 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• GOAL Life-Style Change Intervention to Prevent Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00398060 - Active, not recruiting
  Obesity; Type 2 Diabetes
  
• Vildagliptin 100 mg Once Daily vs. Placebo as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
  ClinicalTrials.gov Identifier: NCT00494884 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00191282 - Active, not recruiting
  Type 2 Diabetes; Acute Myocardial Infarction
  
• Non-Traditional Cardiovascular Risk Factors and Atherosclerosis in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00256607 - Active, not recruiting
  Type 2 Diabetes Mellitus